A carregar...

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis

INTRODUCTION: Adalimumab, a humanized monoclonal antibody targeted against TNF-α, has proved to be successful in the treatment of uveitis. Another anti-TNF-α agent, i.e., infliximab, has been reported of benefit in the treatment of refractory sarcoidosis. The aim of this prospective case series was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Erckens, R. J., Mostard, R. L. M., Wijnen, P. A. H. M., Schouten, J. S., Drent, M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3332360/
https://ncbi.nlm.nih.gov/pubmed/22119879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00417-011-1844-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!